Dey Svetlana 4

What Happened Svetlana Dey, a director of Bluejay Diagnostics, purchased 12,500 shares of the issuer's common stock on March 14, 2026 through a private placement at $2.00 per share, for a total cash outlay of $25,000. This was a direct purchase from the company (transaction code P), i.e., an insider buy rather than a sale.

Key Details

• Transaction date and price: March 14, 2026 — 12,500 shares @ $2.00 each = $25,000.
• Transaction type: Purchase (private placement from the issuer). See footnote F1.
• Filing date: Form 4 filed May 18, 2026. The report was filed late relative to the usual 2-business-day requirement.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Notable footnotes: F1 confirms the shares were bought from the issuer in a private placement. F2 notes Lana Management & Business Research International, LLC is owned by Indranil Dey and Svetlana Dey, and Svetlana Dey has voting and dispositive power over shares held by that entity (indirect ownership/control).

Context This was an insider purchase (primary issuance), meaning the company issued shares rather than the insider buying on the open market. Insider purchases can be viewed by investors as a positive signal, though the amount here ($25k) is modest. The late filing reduces the timeliness of the disclosure for investors; otherwise the transaction is straightforward (no options exercise, gift, or immediate resale reported).